Literature DB >> 28760770

Transcriptional mechanisms that control expression of the macrophage colony-stimulating factor receptor locus.

Rocio Rojo1, Clare Pridans1, David Langlais2, David A Hume3.   

Abstract

The proliferation, differentiation, and survival of cells of the macrophage lineage depends upon signals from the macrophage colony-stimulating factor (CSF) receptor (CSF1R). CSF1R is expressed by embryonic macrophages and induced early in adult hematopoiesis, upon commitment of multipotent progenitors to the myeloid lineage. Transcriptional activation of CSF1R requires interaction between members of the E26 transformation-specific family of transcription factors (Ets) (notably PU.1), C/EBP, RUNX, AP-1/ATF, interferon regulatory factor (IRF), STAT, KLF, REL, FUS/TLS (fused in sarcoma/ranslocated in liposarcoma) families, and conserved regulatory elements within the mouse and human CSF1R locus. One element, the Fms-intronic regulatory element (FIRE), within intron 2, is conserved functionally across all the amniotes. Lineage commitment in multipotent progenitors also requires down-regulation of specific transcription factors such as MYB, FLI1, basic leucine zipper transcriptional factor ATF-like (BATF3), GATA-1, and PAX5 that contribute to differentiation of alternative lineages and repress CSF1R transcription. Many of these transcription factors regulate each other, interact at the protein level, and are themselves downstream targets of CSF1R signaling. Control of CSF1R transcription involves feed-forward and feedback signaling in which CSF1R is both a target and a participant; and dysregulation of CSF1R expression and/or function is associated with numerous pathological conditions. In this review, we describe the regulatory network behind CSF1R expression during differentiation and development of cells of the mononuclear phagocyte system.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  CSF1R; differentiation; macrophages; transcription factors

Mesh:

Substances:

Year:  2017        PMID: 28760770     DOI: 10.1042/CS20170238

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  16 in total

Review 1.  CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.

Authors:  David A Hume; Lena Batoon; Anuj Sehgal; Sahar Keshvari; Katharine M Irvine
Journal:  Curr Osteoporos Rep       Date:  2022-10-05       Impact factor: 5.163

Review 2.  The macrophage: a key player in the pathophysiology of peripheral neuropathies.

Authors:  Zeina Msheik; Mohamed El Massry; Amandine Rovini; Fabrice Billet; Alexis Desmoulière
Journal:  J Neuroinflammation       Date:  2022-04-16       Impact factor: 9.587

3.  Characterization of Subpopulations of Chicken Mononuclear Phagocytes That Express TIM4 and CSF1R.

Authors:  Tuanjun Hu; Zhiguang Wu; Stephen J Bush; Lucy Freem; Lonneke Vervelde; Kim M Summers; David A Hume; Adam Balic; Pete Kaiser
Journal:  J Immunol       Date:  2019-01-09       Impact factor: 5.422

4.  Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia.

Authors:  Kyle A Romine; Tamilla Nechiporuk; Daniel Bottomly; Sophia Jeng; Shannon K McWeeney; Andy Kaempf; M Ryan Corces; Ravindra Majeti; Jeffrey W Tyner
Journal:  Blood Cancer Discov       Date:  2021-07-01

5.  Macrophage colony-stimulating factor increases hepatic macrophage content, liver growth, and lipid accumulation in neonatal rats.

Authors:  Clare Pridans; Kristin A Sauter; Katharine M Irvine; Gemma M Davis; Lucas Lefevre; Anna Raper; Rocio Rojo; Ajit J Nirmal; Philippa Beard; Michael Cheeseman; David A Hume
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-12-21       Impact factor: 4.052

6.  The Transcriptional Network That Controls Growth Arrest and Macrophage Differentiation in the Human Myeloid Leukemia Cell Line THP-1.

Authors:  Iveta Gažová; Lucas Lefevre; Stephen J Bush; Sara Clohisey; Erik Arner; Michiel de Hoon; Jessica Severin; Lucas van Duin; Robin Andersson; Andreas Lengeling; David A Hume; Kim M Summers
Journal:  Front Cell Dev Biol       Date:  2020-07-03

7.  Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.

Authors:  Rocío Rojo; Anna Raper; Derya D Ozdemir; Lucas Lefevre; Kathleen Grabert; Evi Wollscheid-Lengeling; Barry Bradford; Melanie Caruso; Iveta Gazova; Alejandra Sánchez; Zofia M Lisowski; Joana Alves; Irene Molina-Gonzalez; Hayk Davtyan; Rebecca J Lodge; James D Glover; Robert Wallace; David A D Munro; Eyal David; Ido Amit; Véronique E Miron; Josef Priller; Stephen J Jenkins; Giles E Hardingham; Mathew Blurton-Jones; Neil A Mabbott; Kim M Summers; Peter Hohenstein; David A Hume; Clare Pridans
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

8.  Targeting Microglial Population Dynamics in Alzheimer's Disease: Are We Ready for a Potential Impact on Immune Function?

Authors:  Maria Martin-Estebane; Diego Gomez-Nicola
Journal:  Front Cell Neurosci       Date:  2020-06-05       Impact factor: 5.505

9.  The evolution of the macrophage-specific enhancer (Fms intronic regulatory element) within the CSF1R locus of vertebrates.

Authors:  David A Hume; Evi Wollscheid-Lengeling; Rocio Rojo; Clare Pridans
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

10.  Species-Specificity of Transcriptional Regulation and the Response to Lipopolysaccharide in Mammalian Macrophages.

Authors:  Stephen J Bush; Mary E B McCulloch; Zofia M Lisowski; Charity Muriuki; Emily L Clark; Rachel Young; Clare Pridans; James G D Prendergast; Kim M Summers; David A Hume
Journal:  Front Cell Dev Biol       Date:  2020-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.